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Introduction

42
Pregnancy and lactation involve extensive maternal adaptation for foetal and 43 neonatal growth, and to build and replace maternal energy reserves. In rats, dam 44 body mass increases start soon after conception (Cripps & Williams, 1975) , partly by 45 adipose tissue accumulation (Lopez-Luna et al., 1991 , Pujol et al., 2006 . partum, body mass increases again, to above that of non-pregnant controls, despite 47 ~60% loss of adiposity by day 16 lactation (Naismith et al., 1982) . Thus maternal 48 body composition changes, although has not been extensively studied. 49
Hyperphagia during rodent early pregnancy increases food intake by 20% (Crean & 50 Rumsey, 1971 , Trujillo et al., 2011 , with peaks of 50-60% (Cripps & Williams, 1975 ) 51 compared to nulliparous controls. Maternal intake during lactation peaks during week 52 3 lactation to ~250-300% of controls (Crean & Rumsey, 1971 , Cripps & Williams, 53 1975 , Denis et al., 2004 . Hyperphagia during lactation is supported by reduced 54 leptin and decreased adiposity (Woodside et al., 2000) and although appetite 55 increases occur, studies of changes in gut appetite-regulating hormones have so far 56 produced conflicting results. 57
Ghrelin increases with fasting, elevating prior to feeding (Nakazato et al., 2001) and 58 is suppressed by increased leptin in males (Ueno et al., 2004) . In ad lib fed pregnant 59 rats, Taylor et al. (2009) found total ghrelin in plasma and some gut tissues was not 60 suppressed, despite increased leptin mid-pregnancy, whereas another study found 61 ghrelin decreased (Shibata et al., 2004) . During lactation in rats, Taylor et al. (2009) 62 reported no difference in either plasma or tissue total ghrelin, whereas Shibata et al. 63 4 (2004) found lower ghrelin and hypothalamic mRNA during lactation than late 64 pregnancy, suggesting possible systemic reductions after birth. Inconsistencies may 65 be due to non-standardised and/or physiologically inappropriate sampling times, 66 such as during light periods for feeding studies, as rodents consume most food 67 during the active dark phase. This study addressed these issues with dark phase 68 sampling and looking closely at ghrelin-secreting cell location and abundance, to 69 address previously conflicting findings. 70
Satiety hormones PYY and GLP-1 have received less research interest than ghrelin. 71 GLP-1 may have differential abilities to regulate food intake based on nutritional 72 status, with limited effects when fasted (Ronveaux et al., 2014) . Also, GLP-1 73 treatment during proestrus was detrimental to early pregnancy events (Outeirino-74 Iglesias et al., 2015) . During rat pregnancy, plasma total PYY increased (Tovar et al., 75 2004 , Taylor et al., 2009 and gradual increases were documented in descending 76 colon and rectum (Taylor et al., 2009) . Taylor et al. (2009) reported increased 77 plasma PYY at day 5 lactation in rats, paralleled by increases in DC and rectum; also 78 hypothalamic PYY mRNA (days 5 + 15, Suzuki et al., 2014) . It appears plausible that 79 elevated PYY has an important role in rat lactation. Why a purported satiety hormone 80 was elevated, despite pregnancy and lactation-associated hyperphagia, remains to 81 be established. No studies have explored circulating or gut tissue GLP-1 during 82 lactation, hence the current focus. 83
Maternal adaptation during pregnancy and lactation in many animals involves GI tract 84 structural changes (Speakman, 2008 , Reiff et al., 2015 to accommodate large food 85 intake increases, although the mechanisms involved are poorly understood. Stomach 86 tissue mass has been documented to increase during pregnancy and peak by late 87 lactation in rats (Cripps & Williams, 1975 , Taylor et al., 2009 ) and mice (Campbell & 88 7 Body mass and food intake 138 Live body mass was recorded prior to tail bleed (below) and once again after the 139 fasting period, before sacrifice. Food intake was monitored in singly housed females 140 by weighing their food hopper in the days immediately prior to birth and into lactation 141 before the pups started eating solid food. 142 Blood collection and preparation 143 Fed blood samples were taken from a tail vein, between 12:00 and 13:00 hr, under 144 anaesthesia (isoflurane; IsoFlo, Abbott Laboratories, Maidenhead, UK) to minimise 145 stress during collection, as optimised from an earlier study (Johnson et al., 2016) . 146
Lubrithal (VetXX Ltd, Stoke-on-Trent, UK) was applied to the eyes of the rats whilst 147 under anaesthetic to prevent them from drying out and a spray-on dressing (OpSite, 148 Smith & Nephew Medical Ltd, Watford, UK) was applied to the tail tip after sample 149 collection. Once conscious, females were immediately returned to their home cage in 150 their established social groups (pregnancy) or with their pups (lactating). 151
Cage food was removed (access to water maintained) at 08:00 the following day 152 prior to sacrifice between 12:00 and 16:00 hr. Rats were fully anaesthetised and 153 decapitated, and a fasted blood sample was obtained from trunk blood. All blood was 154 collected into EDTA coated tubes with additional protease inhibitor (aprotinin; 155 Trasylol, Bayer plc, Reading, UK). All fed and 1 ml of fasted blood samples were 156 immediately acidified by dilution at 1:10 in buffer (0.1 M ammonium acetate, 0.5 M 157 NaCl, pH 3.6) as recommended for optimal peptide preservation and recovery 158 (Stengel et al., 2009). 159 8 Gastrointestinal tissue measurements 160 The gastrointestinal (GI) tract was measured and sampled in several locations: 161 stomach, small intestine (SI), caecum, large intestine (LI; ascending and descending 162 colon). Measurements of gastrointestinal length were made by emptying the gut of 163 contents and free-floating the tissue in PBS, taking care not to stretch the tissue. 164
Masses were recorded after emptying the gut and blotting the tissue dry on tissue 165
paper. Due to differences in early sample collection, small intestine wet weight has 166 been excluded from analysis for the day 25 lactating dam group and the proestrus 167
controls. 168
Stomachs were removed and mass was recorded after opening along the greater 169 curvature and rinsing in PBS. Once weighed, the stomach incision was extended to 170 cut the stomach in half; one half was snap frozen for peptide extraction (see below) 171 and the body of the other half was fixed in 4% paraformaldehyde overnight, then 172 rinsed in 3 x 10 minutes PBS and placed in 30% sucrose at 4°C for a minimum of 48 173 hours until frozen in OCT for cryosectioning transversely at 10 µm. The small and 174 large intestines were removed whole, emptied, and wet weight and length recorded. 175
The caecum was removed and treated similarly to the stomach (see above). 176
Approximately 1 cm of mid duodenum, proximal ascending colon and proximal 177 descending colon was removed for circumference measurements. Circumference 178 measurements were standardised by measurement after 20 minute incubation in 179 PBS containing 10 -6 M nicardipine hydrochloride to maximally relax the smooth 180 muscle. Nicardipine could not be used to standardise gut length measurements due 181 to the possibility of it interfering with other methodologies (e.g. peptide extraction) 182 that the tissue subsequently underwent; circumference measurements were taken 183 9 from one small piece of tissue. In addition to gut measurements, all of the white 184 adipose tissue (WAT) in the abdominal cavity was carefully removed and weighed. 185 Gastrointestinal tissue preparation for radioimmunoassay 186 Half of each stomach, and ~2 cm portion of mid-duodenum, mid-ascending colon 187 and mid-descending colon were collected and immediately frozen on dry ice. Tissue 188 samples were extracted in 1 ml of 0.5 M glacial acetic acid per 100 g of tissue 189 collected, and boiled in a 100 °C water bath for 20 minutes. The liquid portion of the 190 boiled samples was stored at -20 °C until assayed. 191 Radioimmunoassay 192 As all fed plasma collected was acidified (thereby diluted), this was analysed for each 193 peptide. Fasted acidified plasma was used in ghrelin assays as recommended to 194 stabilise the acyl peptide form, and for PYY and GLP-1 assays, neat un-195 acidified/undiluted fasted plasma was used because concentrations of both of these 196 peptides were expected to be lowest in the fasted state. All samples were analysed in 197 duplicate and according to the manufacturer's protocol for total ghrelin, total PYY and 198 total GLP-1 concentration using radioimmunoassay kits (Millipore, Watford, UK). An 199
Excel spreadsheet was used to calculate sample concentrations from the standard 200 curve, adjusted for sample dilution, with internal controls (provided with the kit) 201 confirming optimal assay performance. All samples were added to assays based on 202 sample type, not by pregnancy or lactation stage. 203
Total ghrelin 204 Preliminary testing measured high concentrations of ghrelin in all samples, so they 205 were diluted ten times by a reduction in sample volume in the assay tubes. Due to 206 cost, fed plasma ghrelin was not measured as a previous study (Johnson et al., 2016) 207 10 found no difference between fed and fasted concentrations. Stomach tissue extracts 208 underwent an additional 1:250 dilution for pregnant and 1:400 for lactating dams. The 209 mean intra-assay variation was 4.4% for plasma and 10.1% for tissue and the mean 210 inter-assay variation was 2.07% for plasma and 9.95% for tissue. 211
Total PYY 212 Fasted plasma samples were added to the kits as suggested by the manufacturers' 213 guidelines. Although fed plasma samples were analysed, the dilution effect of 214 acidifying the samples caused peptide recovery issues so these data are not 215 presentedsee Discussion for why the interpretation of fasted PYY sample 216 concentrations are as equally valid as fed samples during pregnancy. For both 217 pregnant and lactating dams, ascending and descending colon extracts were diluted 218 1:80 prior to addition to the assays. The mean intra-assay variation was 4.4% for 219 plasma and 6.2% for tissue and the mean inter-assay variation was 2.9% for plasma 220 and 7.71% for tissue. 221
Total GLP-1 222 Fasted non-acidified plasma samples were extracted and added to each kit as outlined 223 in the assay protocol. Double the volume of fed acidified plasma was required to 224 undergo the kit extraction protocol in order to bring these samples onto the linear part 225 of the standard curve. Ascending colon samples were diluted 1:80 and descending 226 colon samples were diluted 1:70. The mean intra-assay variation was 4.5% for plasma 227 and 6% for tissue and the mean inter-assay variation was 9.4% for plasma and 3.4% 228 for tissue. 229 11 Immunofluorescence of stomach tissue 230 Stomach sections were stained for total ghrelin peptide using a standard 231 immunofluorescence protocol, with incubations carried out at room temperature. 232
Briefly, slides were incubated with normal horse serum (10%) for 90 minutes, 233 washed in PBS, and incubated overnight with 1:800 goat anti-ghrelin antibody (Santa 234 Cruz Biotechnology, Dallas, USA). After 3 x 10 minute washes in PBS, a biotinylated 235 horse anti-goat IgG (Vector) at 6 µg/ml was applied for 120 minutes, followed by a 236 further wash step. The slides were then incubated with streptavidin fluorescein (4 237 µg/ml) for 120 minutes before a final wash step, and were then cover-slipped using 238
Citifluor (Agar Scientific, Stanstead, UK). Negative controls were: antibody-dilution 239 solution only, primary antibody only, secondary antibody only and streptavidin 240 fluorescein only. 241
Quantification of immunolabelled cell numbers 242 Images were obtained using an Olympus BX fluorescence microscope. In order to 243 perform a manual cell count of each immunoreactive (IR) cell, serial images were 244 taken of the entirety of each section of tissue stained using a x10 objective lens and 245 all IR cells were counted from these images. The programme ImageJ was used to aid 246 manual cell counting, using the cell counter plugin to mark each IR cell in each image. 247
In order to count these images blind, an online list randomiser 248 (http://www.random.org/lists/) was used to assign a random number to each animal 249 number. Each image was then renamed using this random number and cell counting 250 was completed before counts were un-blinded for statistical analysis. Fasted plasma total ghrelin during pregnancy remained consistently reduced (F(7, 280 49)=27.751, P=0.001; Figure 1A ) compared with proestrus controls and all stages of 281 lactation ( Figure 1B ). During pregnancy, ghrelin was significantly (F(2, 18)=3.767, 282 P=0.043) less concentrated in day 18 pregnant (d18P) dams compared with day 4 283 pregnant dams (d4P). By the day of birth (d0L), fasted plasma ghrelin concentrations 284 had increased back to control amounts, and by day 25 of lactation (d25L) had 285 significantly increased (F(3, 24)=4.546, P=0.012) further compared with d0L 286 (P=0.023) and day 5 lactating (d5L; P=0.017) dams ( Figure 1B) . 287
Stomach tissue 288
During pregnancy, the amounts of ghrelin in stomach tissue varied within each dam 289 group, but were reduced in comparison with proestrus controls (P<0.014; Figure 1C ), 290 in d12P (P=0.035). Stomach tissue ghrelin concentration was significantly (Kruskal-291 Wallis, χ2=10.057, 3 df, P=0.018) increased by d0L compared with d12P (P=0.001) 292 and d18P (P=0.036) dams, with a later, significant decrease by d25L (P=0.025) 293 ( Figure 1D ). Although d0L dams had the highest concentration of ghrelin in their 294 stomach tissue out of all of the lactating and pregnant dams, this concentration was 295 similar to that found in the proestrus controls. Ghrelin-immunoreactive (IR) cells in stomach tissue were found throughout the 301 mucosa, predominantly so towards the mucosal-submucosal border, in all groups 302 quantified: proestrus, day 12 pregnant (d12P) and d0L (Figure 2A , B, C). There was 303 no difference in the mucosal area of the stomach, nor in the mean maximum 304 thickness of the mucosa of muscle layers. However, the ghrelin-IR cell density was 305 significantly different between the sample groups (F(2, 17)=29.735, P<0.001) and 306 increased significantly from the proestrus controls to d12P, and dams in the 307 transition stage of parturition (d0L) had a significantly higher ghrelin cell density than 308 in both the other sample groups ( Figure 2D ). 309 Peptide-YY (PYY) concentrations were increased during lactation 314 All colon tissue samples had higher total PYY concentrations than plasma samples 315 (P<0.001; Figure 3C , D, E, F > Figure 3A , B) and GLM analysis of colon region 316 (ascending/descending) found significant main (direct) effects on colon tissue PYY of 317 stage (proestrus, pregnancy or lactation time-points; F(7,101)=4.701, P<0.001; 318 Figure 3C , D, E, F with peak PYY concentrations at day 5 of lactation for ascending 319 colon (P=0.021; Figure 3D ) and descending (P=0.024; Figure 3F ) colon compared 320 with proestrus DC concentrations ( Figure 3F ). 321 15 Plasma 322 Both the pregnant and lactating dams had similar fasted plasma total PYY 323 concentrations, although they were elevated compared with proestrus controls in 324 d10L dams (F(4,35)=4.683, P=0.004; Figure 3A there was a numerical increase, especially in ascending colon, and PYY in the d18P 330 dams in descending colon was two times higher than the proestrus controls (no 331 ascending colon data), suggesting that PYY gradually elevated during pregnancy. 332 PYY concentrations in the ascending colon were significantly (F(6, 46)=3.215, 333 P=0.011) highest in day 5 lactating (d5L) dams -more than double -compared with 334 the start of pregnancy (d4P, P=0.025) and with the end of lactation (d25L, P=0.021). 335
Descending colon PYY concentrations were over three times higher in d5L dams 336 than the proestrus controls (Kruskal-Wallis, χ2=16.955, 7 df, P=0.018). 337 Fed plasma GLP-1 in pregnant dams did not significantly differ (P=0.30, n.s) 360 between groups, but was elevated 2 to 4 times during pregnancy by d12 (P=0.024) 361 compared to proestrus fed nulliparous controls F(3,23)=3.24, P=0.041; Figure 4A ). In 362 contrast, fasted plasma GLP-1 concentrations, were significantly decreased at each 363 stage of pregnancy (F(3, 25)=8.613, P<0.001) compared with proestrus fasted 364 controls, starting at approximately three times lower in early pregnancy at d4P until 365 values were seven times lower by d18P ( Figure 4C ) towards the end of pregnancy. 366
Fasted plasma GLP-1 was significantly decreased during pregnancy (F(2,18)=3.664, 367 P=0.046), with a trend (P=0.057, n.s.) for d18P dams to have less fasted plasma 368 GLP-1 than d4P dams. 369
Dams at the beginning of lactation had even higher (F(4,26)=9.532, P<0.001) fed 370 plasma GLP-1 than during pregnancy, that was approximately six fold more than 371 proestrus controls ( Figure 4B ). Early lactation dams (d0L and d5L) had higher fed 372 GLP-1 values than in all the fasted and fed pregnant (except d12P fed, the third 373 highest time point) and other lactating dams ( Figure 4A , C, D). There were no 374 significant differences in fasted plasma GLP-1 during lactation and amounts were 375 closer to proestrus controls ( Figure 4D ). 376 GLP-1 was higher than descending colon ( Figure 5C , 5D) at d0L (t(6)=3.651, 390 P=0.01) and d10L (t(6)=4.369, P=0.005), therefore GLP-1 concentrations in different 391 regions of the colon were only similar at d5L, due to a possible transient rise in 392 descending colon; and they were also equivalent at d25L when GLP-1 in both tissue 393 regions had reduced to close to control values. 394
Within ascending colon, GLP-1 concentrations were significantly different between 395 the pregnant dams (F(2, 18)=3.919, P=0.039; Figure 5A ) and d18P dams had twice 396 the concentration of ascending colon GLP-1 than day 12 pregnant (d12P) dams, 397 although this did not reach significance with ANOVA post hoc tests (P=0.051, n.s.). 398
Descending colon tissue concentrations of GLP-1 were not significantly different with 399 pregnancy stage, but were approximately two to four times higher than in proestrus 400 controls ( Figure 5C ). 401
Ascending colon GLP-1 concentrations decreased as lactation progressed and were 402 significantly (F(3, 22)=4.164, P=0.018) higher in d0L dams than in d25L dams 403 (P=0.016; Figure 5B ). GLP-1 concentrations in descending colon tissue were 404 significantly different (F(3, 22)=4.493, P=0.013) between the dam groups, and were 405 highest at d0L and d5L before a sharp decrease by d10L (P=0.020), with a 406 significant decrease also found between d0L and d10L (P=0.030) dams ( Figure 5D ). 407
Descending colon GLP-1 concentrations were higher at d0L and d5L (P=0.001; 408 P=0.036) than in the proestrus controls. 409 GLM analysis confirmed that GLP-1 concentrations in late pregnancy (d18P) 410 ascending colon ( Figure 5A ) were higher than all other time-points in both regions of 411 colon (P=0.027-0.000; Figure 5B , C, D) and d10L DC concentrations ( Figure 5D ) 412 19 were lower than all the pregnant AC concentrations (P=0.047-0.000; Figure 5A ), as 413 well as d0 and d5L AC (P=0.016-0.000; Figure 5B The four dams that could be monitored continuously for the most consecutive days 420 around birth, halved their food intake from day 3 to day 1 prior to birth ( Figure 6 ). 421
Food intake rapidly increased into the lactation period, doubling from d1L to d2L. 422
Food intake continued to increase and was highest at d8L, when monitoring stopped. 423
The d8L dams consumed approximately 250% more than the mean daily food intake 424 of all of the normally cycling nulliparous females (15.5 ± 0.09 g, n=43) used in a prior 425 study (Johnson et al., 2016) . As expected, body mass significantly increased (F(2, 18)=12.565, P<0.001) with the 432 advancing stages of pregnancy until birth ( Figure 7A ). Body mass gain continued 433 during lactation (F(2, 18)=12.942, P<0.001; analysis excluding d0L as fed mass 434 included gravid uterus; Figure 7B ) and body mass exceeded that of proestrus control 435 rats (F(7,47)=16.208, P<0.001) by d10L (P=0.038). Mass of abdominal cavity white 436 20 adipose tissue (WAT) was significantly largest (F(2, 18)=6.248, P=0.009; Figure 7C ) 437 by d18P, and showed a significant decline after d0L (F(3, 24)=13.899, P<0.001; 438 Figure 7D ) until the end of lactation. Day 18 pregnant dams had higher abdominal 439 WAT values than proestrus nulliparous controls, while control rats had up to three 440 times more WAT (F(7,49)=10.495, P<0.001) than rats at day 10 and day 25 of 441 lactation (P<0.009; P<0.001; Figure 7C Stomach tissue wet mass did not change throughout pregnancy and remained 449 similar to the controls ( Figure 8A ). During lactation, stomach mass significantly 450 increased (Kruskal Wallis, χ2=15.015, 3 df, P=0.002), becoming heavier than early 451 pregnancy time points and control values by d10L, and d25L dams had significantly 452 heavier stomachs than d0L (P=0.018) and d5L (P=0.002) dams ( Figure 8b ) and all 453 pregnant groups (F(7,48)=12.648, P<0.001). 454
Similarly, caecum wet mass did not change significantly during pregnancy ( Figure  455 8C), but was significantly (F(3, 24)=40.888, P<0.001) heavier in both the d10L and 456 d25L dams than in the d0L (P<0.001) and d5L (P<0.001) dams ( Figure 8D ) and all 457 pregnant groups (F(7,48)=12.648, P<0.001). Additionally, d5L dam caecum mass 458 was heavier than in d4P animals (P=0.013). 459 Figure 9C ) small intestines than 466 d4P dams. Further growth continued during lactation: d5L dams had significantly 467 heavier small intestines than d0L (P=0.022) dams, and in mid-lactation, d10L dams 468 had heavier (F(2,18)=39.220, P<0.001) small intestines than both d0L (P<0.001) and 469 d5L (P<0.001) dams ( Figure 9B ); there were no data for d25L (see methods). The 470 small intestine also significantly increased in length in later lactation (F(3, 471 24)=17.944, P<0.001; Figure 9D ), being significantly longer in both d10L dams 472 (where peak growth had been reached) and d25L dams, than in d0L (P<0.001) and 473 d5L (P<0.001) dams. Day 10 and 25 lactation dams had approximately 48% longer 474 small intestines than proestrus controls, d0L and d5L dams and all pregnant groups 475 (F(7,49)=20.546, P<0.001). 476 Large intestine mass increased during pregnancy and lactation, with 477 length only increased by late lactation, peaking d25L 478 Large intestines of d18P dams were significantly heavier (F(2, 18)=7.931, P=0.003; 479 Figure 9E ) than the d4P (P=0.003) and d12P (P=0.046) groups, although they were 480 significantly (F(2, 18)=5.506, P=0.014) shorter in d12P dams than in d4P (P=0.044) 481 and d18P (P=0.017) dams ( Figure 9G ). Dams at the end of the lactation period (d25L) 482 had significantly (F(3, 19)=19.322, P<0.001) heavier large intestine tissue than d0L 483 22 (P<0.001), d5L (P<0.001) and d10L (P=0.001) dams ( Figure 9F ) and all pregnant dam 484 groups (F(7,47)=11.104, P<0.001). Dams also had significantly shorter (F(3, 485 24)=15.519, P<0.001) large intestines at d0L (P<0.001) and d5L (P=0.001) compared 486 to d25L dams, with d0L dams also having shorter large intestines than d10L (P=0.004) 487 dams ( Figure 9H ). Both the pregnant dams and d5L dams had similar large intestine 488 lengths to the proestrus controls ( Figure 9G, H) . Gut circumference measurements for duodenum and ascending colon were greater in 496 the pregnant dams, significantly at d4P (F(7,49)=4.108; 5.906, P<0.001) compared 497 with proestrus controls, with only descending colon values similar ( Figure 10A) . 498
Between the different pregnant groups, neither the duodenum nor descending colon 499 tissue circumferences differed, however, ascending colon circumference was 500 significantly wider (F(2, 18)=3.953, P=0.038) in early pregnant d4P dams compared 501 with d12P dams (P=0.033), which coincided with reduced large intestine length in 502 d12P rats. d4P and d18P rats also had wider AC values than d25L rats (Figure 10 A,  503   B ). 504
Lactating dams at d10 had larger duodenum circumferences than proestrus controls 505 ( Figure 10B) , at the same time as the small and large intestine growth increases at 506 23 d10L ( Figure 9 ). By late lactation/weaning duodenum circumference (F(3, 24)=3.052, 507 P=0.048) had significantly reduced by d25L from the earlier peak at d10L (P=0.046). 508
Ascending colon circumference (F(3, 24)=6.506, P=0.002) was also significantly 509 increased in early, compared to late lactation: d0L (P=0.045), d5L (P=0.035), and 510 peaked in d10L (P=0.001) dams compared to d25L dams and proestrus controls 511 ( Figure 10B ). The reduction in late lactation coincided with peak large intestine 512 increases (Figure 9 ). 513
Circumference of descending colon (F(3, 24)=4.346, P=0.014) was also significantly 514 smaller in d25L than in d10L (P=0.012) dams. Both ascending and descending 515 circumferences at d25L were reduced compared to earlier in lactation and were also 516 smaller than proestrus controlsthis coincided with the large intestine peak mass and 517 length increases at d25L. 518 Ghrelin stimulates appetite, thus is expected to increase during pregnancy. However, 527 fasted plasma ghrelin was decreased between d4P and d18P, consistent with animal 528 (Shibata et al., 2004) and human studies (Fuglsang et al., 2005 , Tham et al., 2009 Suppression of this appetite-stimulating signal occurred throughout pregnancy for 530 24 reasons unknown, and despite ghrelin-secreting cell increases by d12P compared 531 with proestrus controls that continued until the onset of lactation. Unknown 532 mechanisms underlie peripheral ghrelin suppression during early pregnancy, 533 although increasing leptin may be involved later. What initiates and supports early 534 pregnancy hyperphagia if the only peripheral orexigenic hormone is not involved? 535
These observations caution against endogenous appetite hormone use as body 536 mass control therapies during pregnancy until established that alterations are not 537 harmful to developing embryos. 538
Reduction in food intake before birth followed low systemic ghrelin at d18P, and the 539 100% increase post-partum occurred after peak ghrelin-IR cells and the highest 540 stomach ghrelin measured. Fasted plasma ghrelin increased from early to d25 541 lactation; dams had 20% higher than proestrus controls. Shibata et al. (2004) 542 reported no changes to fed plasma ghrelin in rats between d5L and d15L, and 543
Suzuki et al. (2014) likewise found no difference in fed acyl ghrelin. The plasma 544 differences we report are novel and arguably more reliable, as samples were both 545 fasted and taken in the more physiologically-relevant dark phase. Late lactation 546 ghrelin increases could be explained by decreased WAT/reduced leptin (Woodside 547 et al., 2000 , Taylor et al., 2009 , which in turn could unsuppress circulating ghrelin 548 (Ueno et al., 2004) . Dams still need to eat more to replenish energy reserves 549 following weaning (very low WAT masses d25L), despite body mass increases (see 550 later discussion). Dams had larger stomach masses by lactation end, with potentially 551 more ghrelin-secretory cells following the measured increase at parturition, 552 contributing to higher circulating ghrelin by d25L. 553 PYY was not altered during pregnancy, agreeing with Valsamakis et al. (2010) , 554 although values were higher than non-pregnant. Fasted plasma PYY was 63% 555 25 higher than controls at d10L, demonstrating elevated peripheral concentrations, 556 following earlier peaks in d5L colon tissue. Other studies report plasma PYY fed and 557 fasted d5L peaks (Tovar et al., 2004 , Taylor et al., 2009 Suzuki et al., 2014) . 558
Together, these studies indicate that fed/fasting status of ad lib fed dams does not 559 diminish observed PYY peaks. During lactation, AC and DC PYY peaked in d5L 560 dams, similar to d5L plasma peaks (Taylor et al., 2009; Suzuki et al., 2014) . Despite 561 gut region/timing differences between studies, increases were consistent. It remains 562 to be established why a purported satiety hormone elevates during physiological 563 states of hyperphagia; some explanations relating to GI remodelling are explored 564 below. 565 GLP-1 is a satiety hormone and decreases in insulin-resistant states (Toft-Nielsen et 566 al., 2001 , Muscelli et al., 2008 , Lim et al., 2009 ). Pregnancy-associated insulin 567 resistance could explain decreases in fasted plasma GLP-1 throughout pregnancy, 568
with lowest values by d18P. As with PYY, there were unexpected increases, as fed 569 GLP-1 was greatly elevated (25x) in pregnancy and highest in d18P AC tissue. 570
Likewise, fed GLP-1 was also very high with d0 and d5 peaks in lactation; the main 571 source of circulating GLP-1 was likely AC, as DC was very low after d5L. In contrast, 572 human studies found no GLP-1 lactational changes (Larson-Meyer et al., 2016) . 573
The current study found both PYY and GLP-1, so-called 'satiety' hormones, to be 574 increased, with high values persistent in lactation despite food intake increasing 199% 575 by d5L. High sustained PYY and GLP-1 may initiate the ileal brake mechanism (Lin et 576 al., 1996; Maljaars et al., 2008) , against a low ghrelin background and reduced gastric 577 emptying (Levin et al., 2006) , thus slowing gut transit times to allow digestion and 578 nutrient extraction from increased feed. The currently accepted role of PYY and GLP-579 1 is to rise in response to intake and signal fullness, causing a compensatory appetite 580 26 reduction but the opposite occurred in pregnant and lactating dams, despite 581 hyperphagia (except briefly at parturition). 582
This study also investigated physical gut changes to help explain contradictory 583 'appetite' hormone observations. Following birth, dam body mass increased although 584 WAT reserves decreased, reflecting body composition changes. We explored GI tract 585 remodelling and have described a number of modifications that show how dam 586 physiology altered to accommodate lactational demands of eight growing pups. 587
Neither stomach nor caecum mass changed across pregnancy, but wet masses 588 increased by end of lactation, consistent with previous studies (Cripps & Williams. 589 1975; Taylor et al., 2009) . Small intestine wet weight and length increased between 590 d4P and d18P, by 20% and 15%. This increase in size and capacity could be an early, 591 rapid adaptation to increase absorption of nutrients from more food, to support the 592 production of reproductive tissues; also building reserves for lactation. Lactating dams 593 had further increased small intestine wet weight and length by d10L, 50% longer than 594 non-pregnant controls. Large intestine mass increased with pregnancy and was even 595 heavier by d25L, in agreement with Cripps & Williams (1975) . Any variation in adaptive 596 changes between studies are likely due to differences in diet composition and food 597 quantities consumed. In our study, there was consistency of timing of SI and LI tissue 598 expansion with increased stomach and caecum masses, although SI increases 599 peaked earlier at d10 of lactation, whereas LI growth continued to d25L. 600
Gut circumferences provided further novel information. Although neither duodenum 601 nor DC were different between pregnancy stages, AC circumferences were. Changes 602 along the GI tract could be an additional mechanism to support pregnancy/lactation, 603 increasing surface area and gut capacity to process nutrients from more food, altering 604 transit times. Day 4P dams had largest AC circumferences, with higher values in 605 27 duodenum and DC, compared to controls. These data may reflect the earliest 606 pregnancy adaptation to rapidly increase capacity, especially of caecum to hold more 607 food (as microbiome composition changes: Mann et al., 2018) , prior to gut lengthening 608 later in pregnancy, further increasing surface area. In early pregnancy there are less 609 competing demands for space between gravid uterus and abdominal organs, making 610 temporary expansion possible. 611
In lactating dams, duodenum, AC and DC had increased circumferences leading up 612 to d10L peaks, with decreases from d10L to d25L. Narrowing of colon circumferences 613 coincided with maximal tissue hypertrophyincreased lengths and massesand 614 capacity, which may reflect final adjustments to maximal feed intakes during lactation. 615
Thus, in addition to later gut hypertrophy, early maternal adaptations to hyperphagia 616 included widening/dilation of specific portions of GI tract to accommodate greater 617 volumes of food and aid nutrient acquisition. In lactating rats on restricted diets, 618 Campbell and Fell (1964) found SI was similarly dilated, with only partial hypertrophy 619 compared to ad lib fed. That study also reported that the absorptive capacity of SI did 620 not differ between nulliparous and lactating rats with varying gut hypertrophy, 621
suggesting changes are proportionate to requirements. Datta et al. (1995) also 622 reported that food restriction prevented SI hypertrophy and Tovar et al. (2004) found 623 a 30% food restriction completely suppressed pregnancy-associated PYY rises. 624
Combined, these findings indicate both physical (food mass) and hormonal (PYY/GLP-625 1) stimulation are needed to initiate and maintain gut growth, as has been expounded 626 in this study, where extensive organ remodelling, with increases in SI and LI masses 627 and lengths, occurred during later lactation, coincident with elevations of and following 628 PYY and GLP-1 peak concentrations that had occurred earlier in lactation. 629 28 PYY and GLP-1 are co-secreted, with GLP-2 (Mojsov et al., 1986) ; and have 630 previously been linked with gut growth in adult female mice (PYY: Gomez et al., 1995) , 631 male mice (Drucker et al., 1996) and rats (GLP-2 > GLP-1: Ghatei et al., 2001) . PYY 632 and GLP-2 cause substantial intestinal hypertrophy, with smaller GLP-1 increases. 633
Our findings of gut hypertrophy under conditions of high PYY and very high GLP-1 634 concentrations highlight that it is imperative to further elucidate the role of L-cells and 635 their secretory products after gut surgeries for body mass reduction, as these 636 techniques lead to rapidly increased concentrations of appetite hormones 637 (Chandarana et al., 2011) and may be stimulating intestinal growth in attempts to 638 regenerate remaining gut tissues (le Roux et al., 2010) . 639
This study has revealed that when maternal nutritional requirements are highest, 640 additional and unexpected supportive changes to increased intake occur in 'appetite' 641 hormones PYY and GLP-1. These hormonal alterations are likely to be homeorhetic 642 adjustments (Bauman and Currie, 1980) to pregnancy, and especially lactation, that 643 have a more pronounced influence on GI remodelling, than satiety. The observed 644 structural changes contribute towards meeting dam enhanced energy requirements 645 and maximising nutrient recovery from the increased intake of pregnancy and more 646 extreme hyperphagia of lactation. They may aid feeding efficiency via altered 647 metabolism and nutrient uptake, slowing food passage rate (Hammond, 1997) and 648 facilitate caecum microbe diversity changes (Mann et al., 2018) . Our observations 649
show how gut adaptations continue until (and possibly persist beyond) weaning, in 650 rat dams that raise litters of 8 pups. 651
In conclusion, despite hyperphagia, fasted plasma ghrelin was suppressed in 652 pregnancy, although ghrelin-IR cells and stomach ghrelin were highest at birth, 653 supporting onset of lactation-associated hyperphagia. Plasma fed GLP-1 was 654 29 elevated during pregnancy, and increases of colon PYY and GLP-1 during early 655 lactation were associated with GI expansion, not satiety. 01; a>b, a>b, 936 P<0.001, c>d, P<0.01, e>f, e>f, P<0.05. (d4P, day 4 pregnant, n=7; d12P, day 12 937 pregnant, n=7; d18P, day 18 pregnant, n=7 ; d0L, day 0 of lactation, n=7; d5L, day 5 938 of lactation, n=7; d10L, day 10 of lactation, n=7; d25L, day 25 of lactation, n=7. Dotted 939 line represents mean of proestrus controls, n=6). 940
